BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16679481)

  • 1. Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining.
    Matos AJ; Faustino AM; Lopes C; Rutteman GR; Gärtner F
    Vet Rec; 2006 May; 158(18):626-30. PubMed ID: 16679481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of regional lymph node status in canine mammary carcinomas.
    Szczubiał M; Łopuszynski W
    Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mammary carcinoma in female dogs: a new routine diagnosis by the detection of occult micrometastases in the regional lymph nodes].
    Busch U; Rudolph R
    Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):43-6. PubMed ID: 7786275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mammary carcinoma of the female dog: clinical relevance of the immunohistochemical demonstration of micrometastases in the regional lymph nodes].
    Busch U; Rudolph R
    Tierarztl Prax; 1995 Jun; 23(3):280-6. PubMed ID: 7545833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytological detection of lymph node metastases in dogs with malignant epithelial tumours.
    Höinghaus R; von Wasielewski R; Hewicker-Trautwein M; Freund M; Mischke R
    J Comp Pathol; 2007 Jul; 137(1):1-8. PubMed ID: 17543325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
    Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
    J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis between multilevel sectioning with conventional haematoxylin and eosin staining and immunohistochemistry for detecting nodal micrometastases with stage I and II colorectal cancers.
    Wong YP; Shah SA; Shaari N; Mohamad Esa MS; Sagap I; Isa NM
    Asian Pac J Cancer Prev; 2014; 15(4):1725-30. PubMed ID: 24641399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
    Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
    Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
    Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
    Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of occult micrometastases and isolated tumour cells within regional lymph nodes of previously diagnosed non-metastatic (stage 0) canine carcinomas.
    Casey KM; Steffey MA; Affolter VK
    Vet Comp Oncol; 2017 Sep; 15(3):785-792. PubMed ID: 27135991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
    Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
    J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
    Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
    Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
    Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
    Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
    Zuccari DA; Santana AE; Cury PM; Cordeiro JA
    Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the diagnosis and treatment of canine mammary tumours: Immunohistochemical markers as prognostic tools.
    Morris JS
    Vet J; 2010 Apr; 184(1):3-4. PubMed ID: 19713137
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras.
    Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Hatakeyama K
    Histopathology; 1998 Mar; 32(3):199-208. PubMed ID: 9568504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.